Regulation of homeopathic drug products

American Journal of Health-System Pharmacy

Volumn 63, Issue 1, 2006, Pages 86-91

  Borneman, John P ^a,b,d   Field, Robert I ^c  

^a Homeopathic Pharmacopoeia Convention of the United States   (United States)

^b Box 87   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

^d Box 87 ^*  (United States)

Author keywords

Alternative medicine; Food and Drug Administration (U.S.); Food, Drug, and Cosmetic Act; Homeopathic Pharmacopoeia; Homeopathy; Regulations; Toxicity

Indexed keywords

ENZYME; GLYCERYL TRINITRATE; HOMEOPATHIC AGENT; NEW DRUG; NON PRESCRIPTION DRUG; VACCINE; VITAMIN;

ALLOPATHY; CLINICAL PHARMACY; DILUTION; DRUG APPROVAL; DRUG MEGADOSE; DRUG USE; GOOD MANUFACTURING PRACTICE; HISTORY OF MEDICINE; HOMEOPATHY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SYMPTOMATOLOGY; UNITED STATES;

EID: 30344443331     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050105     Document Type: Review

References (23)

1. Committee on the Use of Complementary and Alternative Medicines by the American Public. Complementary and alternative medicine in the United States. Washington, DC: Institute of Medicine; 2005.
2. IRI data report. 12 months trailing December 31, 2004. Information Resources, Inc.; 2004.
3. Report of survey for the U.S. homeopathic industry. Santa Rosa, CA: American Association of Homeopathic Pharmacists; 2002 Sep.
4. Barnes PM, Powell-Griner E, McFann K et al. Complementary and alternative medicine use among adults: United States, 2002. Advance data from vital and health statistics; no. 343. Hyattsville, MD: National Center for Health Statistics, 2004; DHHS publication no. 2004-1250 04-0342 (05/04).
5. Eisenberg DM, Kessler RC, Foster C et al. Unconventional medicine in the United States. N Engl J Med. 1993; 328:246-52.
6. Kayne SB. Homeopathic pharmacy: an introduction and handbook. Edinburgh, Scotland: Churchill Livingstone; 1997.
7. Kayne SB. Complementary therapies for pharmacists. London: Pharmaceutical Press; 2002.
8. Food, Drug, and Cosmetic Act of 1938, Pub. L. 103-417, 52 Sta. 1041 (1938), as amended and codified in 21 U.S.C. §321(g)(1) (1938).
9. Homeopathic Pharmacopoeia Convention of the United States. Overview. www.hpus.com/overview.php (accessed 2005 Nov 28).
10. Baker C, Borneman J, Abecassis J et al. The homoeopathic pharmacopoeia of the United States. Southeastern, PA: Homeopathic Pharmacopoeia Convention of the United States; 2002.
11. Coulter H. Divided legacy: the conflict between homeopathy and the American Medical Association. Berkeley, CA: North Atlantic Books; 1973.
12. Starr P. The social transformation of American medicine. New York: Basic Books; 1982.
13. History of homeopathy. Omaha, NE: Creighton University School of Medicine; 2002. http://altmed.creighton.edu/Homeopathy/history.htm (accessed 2005 Nov 28).
14. Junod S. An alternative perspective: homeopathic drugs, Royal Copeland, and federal drug regulation. Food Drug Law J. 2000; 55:161-84.
15. Robins N. Copeland's cure. New York: Knopf; 2005.
16. Winston J. Influenza-1918: homeopathy to the rescue. N Engl J Homeopathy. 1998; 7(1):112-5.
17. Hoover TA. Homeopathic prophylaxis: fact or fiction, www.homeopathic.org/ crtoddh.htm (accessed 2005 Nov 28).
18. Dietary Supplement Health and Education Act of 1994. www.fda.gov/opacom/ laws/dshea.html#sec5 (accessed 2005 Nov 28).
19. Consumer Healthcare Products Association. Paying for OTCs with pre-tax dollars. www.chpa-info.org/web/for_consumers/otcs_pretax.aspx (accessed 2005 Nov 28).
20. United States Food and Drug Administration Center for Food Safety and Applied Nutrition. Dietary supplements: overview. www.cfsan.fda.gov/~dms/ supplmnt.html (accessed 2005 Nov 28).
21. Neergaard L. FDA takes stand on dietary supplements. Associated Press; 2003 Mar 7.
22. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Fed Regist. 2000; 65:1000-50.
23. Working agreement between FDA and FDC. 3 Trade Reg. Rep. (CCH) 9850.01 (1971).